Learn more about whether Becton, Dickinson and Company or Intuitive Surgical, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Becton, Dickinson and Company (NYSE:BDX – Get Free Report) had its target price hoisted by analysts at Piper Sandler from $275.00 to $280.00 in a research report issued on Tuesday,Benzinga reports.

Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $249.08 which represents a slight increase of $0.38 or 0.15% from the prior close of $248.7. The stock opened at $248.68 and ...

Becton, Dickinson and Company (NYSE:BDX – Get Free Report) announced that its board has authorized a share buyback program on ...

Becton, Dickinson and Company announced it repurchased $750M in BD stock to date in FY25. In addition, the board has authorized the company to ...

Piper Sandler raised the firm’s price target on Becton Dickinson (BDX) to $280 from $275 and keeps an Overweight rating on the shares. The firm ...

This was the stock's third consecutive day of gains.

Edwards Lifesciences Veteran Katie Szyman Named Next Masimo CEO. The Irvine-based medical device maker last week announced ...

Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $243.45 which represents a slight increase of $2.98 or 1.24% from the prior close of $240.47. The stock opened at $239 and ...

Becton, Dickinson and Company (NYSE:BDX), a leading player in the medical technology sector with a market capitalization of ...

Invent.ai is working with Alo Yoga, a luxury activewear brand, to transform the retailers inventory planning and ...

The new versions of BD flow cytometer instrument software compatible with Biosero automation software for the BD FACSymphony A1™ Cell Analyzer, BD FACSymphony™ A5 SE Cell Anal ...